教育背景

2009.07 武汉大学，医学学士，医学硕士

2013.11 德国波恩大学眼科医院，医学博士

工作经历

2025.07-至今 新加坡国立大学眼科系，助理教授（终身教职）

2026.01-至今 新加坡国立大学生物医学工程系，助理教授（终身教职）

2025.08-至今 新加坡科技研究局分子与细胞生物学研究所，高级科学家 II（联合任命）

2026.03-至今 新加坡眼科研究所（SERI），研究科学家（联合任命）

研究领域

干细胞生物学、组织工程（支架开发）、外科动物模型及临床研究。

荣誉奖项

2026. 02 Clinician Scientist Award, National Medical Research Council (NMRC), Singapore
2025. 12 Research Accreditation Programme- Award for Financial Year 2023 Scientific Publications, Singapore Eye Research Institute, Singapore
2023. 10 Yong Investigator Award, Tissue Engineering and Regenerative Medicine International Society (TERMIS), Hong Kong, China

代表性论文

48 publications, total IF 316.964, H-index 21, FWCI 2.31, 28 articles in Top 10%, 41 articles in Q1.

[1]  Liu H, Wong DSL, Parikh BH, Hao M, Tan QSW, Chee PL, Lou X, Kai D, Lingam G, Huang D*, Su X*, Liu Z*, Single-cell-pore-sized 3D printed scaffolds for retinal pigment epithelial cell therapy. Acta Biomater., 2025; DOI: 10.1016/j.actbio.2025.10.033.

[2]  ^§Liu Z*, Wong DSL, Parikh BH, Li J, Al-Mubaarak A, Liu H, Yang B, Bhargava M, Li Z, Loh XJ*, Su X*, Development of a biodegradable smooth-surface microcarrier for retinal pigment epithelial cell expansion and maturation. Biomaterials, 2025; DOI: 10.1016/j.biomaterials.2025.123742

[3]  Ali SM, Parikh BH, Tan QSW, Hübner B, Kozyrina AN, Banerjee A, Zhao J, Goh D, Bogireddi H, Yeo SW, Wong DSL, Xu J, Tan KC, Liu Z, Le Y-Z, Barathi VA, Cheong KH, Di Russo J, Ludwig A, Hunziker W*, Su X*, ZO-1/Tjp1 and ZO-2/Tjp2 deletion in retinal pigment epithelium causes progressive retinal degeneration, iScience 2025; DOI: 10.1016/j.isci.2025.113673.

[4]  Zhao X, Lin Q, Seah I, Tan QSW, Goh RZR, Mehta KN, Liu Z, Tan A, How SEA, Sim B, Mota-Santiago P, Kirby N, Leow Y, Lim CC, Boo YJ, Goh SS, Lim JYC, Loh XJ, Su X. One-year ultralong intravitreal release of tyrosine kinase inhibitor from supramolecular temperature-responsive hydrogel. Biomacromolecules, 2025; DOI: 10.1021/acs.biomac.5c01212.

[5]  Chee PL, Hao M, Liu G, Yew PYM, Kim E, Liu H, Sathasivam T, Xu G, Liu Z*, Kai D*. Functional scaffolds design strategies for retinal repair and regeneration. Mater. Today Bio., 2025; DOI: 10.1016/j.mtbio.2025.102283.

[6]  ^§Schulz A*, Keskar M, Swindle-Reilly KE, Junge V, Parikh BH, Su X, Liu Z*, Seah I. Replacing the vitreous body with hydrogels: rationale and strategies. Prog. Retin. Eye Res. 2025; DOI: 10.1016/j.preteyeres.2025.101389.

[7]  ^§Wang W, Wang N, Zhao X, Su X*, Liu Z*. Recent advancements in polymer science for retinal diseases: New frontiers in drug delivery systems. APL Bioeng. 2025; DOI: 10.1063/5.0264382. Featured Article.

[8]  Soundararajan L, Surendran H, Patlolla N, Battu R, Stoddard J, Arrizabalaga S, Liu Z, Lingam G, Su X, Ryals RC, Pal R. Allogeneic RPE cell suspension manufactured at scale demonstrating preclinical safety and efficacy led to IND approval. npj Reg. Med., 2025; 10:19. DOI: 10.1038/s41536-025-00407-0.

[9]  Xu Y, Liu X, Wu N, Long Y, Ren J, Wang Y, Su X, Liu Z, Fujinami-Yokokawa Yu, Fujinami K, Chen F, Meng X, Liu Y. Investigating microperimetric features in bietti crystalline dystrophy patients: a cross-sectional longitudinal study in a large cohort. Invest. Ophthalmol. Vis. Sci. 2024; 65(13):27. DOI: 10.1167/iovs.65.13.27.

[10]  ^§Liu H, Huang SS, Lingam G, Kai D, Su X*, Liu Z*. Advances in retinal pigment epithelial cell transplantation for retinal degenerative diseases. Stem Cell Res. Ther, 2024; 15:390. DOI: 10.1186/s13287-024-04007-5.

NUS网址

https://cde.nus.edu.sg/bme/staff/dr-liu-zengping/